Literature DB >> 8739398

The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample.

H J Gertz1, J H Xuereb, F A Huppert, C Brayne, H Krüger, M A McGee, E S Paykel, C R Harrington, E B Mukaetova-Ladinska, D W O'Connor, C M Wischik.   

Abstract

The neuropathological staging model proposed by Braak and Braak (1991) implies that the evolution of neurofibrillary pathology follows a predictable sequence and can be ordered in a regular regional hierarchy. A total of 42 cases of an elderly population sample, which had been prospectively clinically assessed, were examined. Clinical diagnosis was made according to the CAMDEX criteria, and the sample reported here did not include cases were vascular dementia according to the criteria proposed by Chui et al. (1991). The neuropathological staging procedure was applied as originally proposed by Braak and Braak (1991). In addition, in all cortical laminae and regions which are essential for the staging model neurofibrillary tangles were quantified. Demented cases had significantly more areas involved and more advanced neuropathological stages. Cases with stages 1-3 tended to be non-demented, and cases with stages 4-6 tended to be demented. However, there was a considerable degree of overlap and no clear-cut threshold could be established. This brings into question the diagnostic value of the staging model.

Entities:  

Mesh:

Year:  1996        PMID: 8739398     DOI: 10.1007/bf02189114

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  12 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  The cortex of the primary auditory area in Alzheimer's disease.

Authors:  M M Esiri; R C Pearson; T P Powell
Journal:  Brain Res       Date:  1986-02-26       Impact factor: 3.252

3.  Observations on the brains of non-demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1968 Sep-Oct       Impact factor: 3.181

Review 4.  Computational analysis of the role of the hippocampus in memory.

Authors:  A Treves; E T Rolls
Journal:  Hippocampus       Date:  1994-06       Impact factor: 3.899

5.  Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; C R Harrington; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 6.  Research and Alzheimer's disease: an epidemiological perspective.

Authors:  C Brayne
Journal:  Psychol Med       Date:  1993-05       Impact factor: 7.723

7.  Plaques, tangles and dementia. A quantitative study.

Authors:  G K Wilcock; M M Esiri
Journal:  J Neurol Sci       Date:  1982-11       Impact factor: 3.181

8.  Incidence of dementia in a population older than 75 years in the United Kingdom.

Authors:  E S Paykel; C Brayne; F A Huppert; C Gill; C Barkley; E Gehlhaar; L Beardsall; D M Girling; P Pollitt; D O'Connor
Journal:  Arch Gen Psychiatry       Date:  1994-04

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

View more
  10 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Cognitive reserve in aging.

Authors:  A M Tucker; Y Stern
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

Review 3.  [Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].

Authors:  H-J Gertz; A Kurz
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

4.  Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Authors:  Val J Lowe; Heather J Wiste; Matthew L Senjem; Stephen D Weigand; Terry M Therneau; Bradley F Boeve; Keith A Josephs; Ping Fang; Mukesh K Pandey; Melissa E Murray; Kejal Kantarci; David T Jones; Prashanthi Vemuri; Jonathan Graff-Radford; Christopher G Schwarz; Mary M Machulda; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

5.  Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.

Authors:  Val J Lowe; Tyler J Bruinsma; Heather J Wiste; Hoon-Ki Min; Stephen D Weigand; Ping Fang; Matthew L Senjem; Terry M Therneau; Bradley F Boeve; Keith A Josephs; Mukesh K Pandey; Melissa E Murray; Kejal Kantarci; David T Jones; Prashanthi Vemuri; Jonathan Graff-Radford; Christopher G Schwarz; Mary M Machulda; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Neurology       Date:  2019-05-30       Impact factor: 9.910

6.  Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.

Authors:  Yuu Yamazaki; Tomoyasu Matsubara; Tetsuya Takahashi; Takashi Kurashige; Eisuke Dohi; Masanori Hiji; Yoshito Nagano; Takemori Yamawaki; Masayasu Matsumoto
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

Review 7.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

Review 8.  Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.

Authors:  Claude M Wischik; Björn O Schelter; Damon J Wischik; John M D Storey; Charles R Harrington
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants.

Authors:  Val J Lowe; Tyler J Bruinsma; Hoon-Ki Min; Emily S Lundt; Ping Fang; Matthew L Senjem; Bradley F Boeve; Keith A Josephs; Mukesh K Pandey; Melissa E Murray; Kejal Kantarci; David T Jones; Christopher G Schwarz; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  Alzheimers Dement (Amst)       Date:  2018-02-07

10.  Association of deposition of tau and amyloid-β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients.

Authors:  Yoko Shigemoto; Daichi Sone; Norihide Maikusa; Nobuyuki Okamura; Shozo Furumoto; Yukitsuka Kudo; Masayo Ogawa; Harumasa Takano; Yuma Yokoi; Masuhiro Sakata; Tadashi Tsukamoto; Koichi Kato; Noriko Sato; Hiroshi Matsuda
Journal:  Brain Behav       Date:  2018-10-24       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.